Clinical Trial Update: Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of NOVA22007 (cyclosporin 0.1%) versus vehicle in moderate to severe dry eye syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• NOVA22007 (cyclosporin)

Snippet

Sponsor: Santen SAS | Conditions: Moderate to Severe Dry Eye Syndrome | Phase 3 | Status: COMPLETED